Collecting data on hip growth in newborns using ultrasound
Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound
This study is trying to collect information on hip growth in newborns using ultrasound to help doctors better understand and treat hip dysplasia in infants.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 75 (estimated) |
| Ages | N/A to 6 Weeks |
| Sex | All |
| Sponsor | University of California, San Francisco Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Fresno, California) |
| Trial ID | NCT03109444 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather normative data on ultrasound radiographic parameters for evaluating hip dysplasia in infants born between 32 and 46 weeks of gestational age. Conducted at Community Regional Medical Center, the study involves obtaining consent from legally authorized representatives of newborns and performing non-invasive hip ultrasounds during their hospital stay. The collected data will be used to develop a growth chart that includes standard deviations, aiding in the treatment of suspected hip dysplasia. Follow-up ultrasounds will be scheduled weekly until the newborn's hips meet normal morphology criteria or they reach six weeks of corrected age.
Who should consider this trial
Good fit: Ideal candidates include newborns born at Community Regional Medical Center, both term and pre-mature, who are over 32 weeks gestational age.
Not a fit: Patients with known neuromuscular or genetic conditions predisposing them to hip dysplasia, or those who cannot follow up, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a standardized growth chart for assessing hip development in newborns, improving early detection and treatment of hip dysplasia.
How similar studies have performed: While similar studies have explored hip dysplasia, this approach of developing a normative growth chart using ultrasound data in this specific age group is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * newborns born at CRMC (term newborns and pre-mature newborns over 32 weeks gestational age. * newborns in NICU * newborns on postpartum floor * single birth * multiple births * normal presentation * breach presentation Exclusion Criteria: * known neuromuscular or genetic condition predisposing infant to hip dysplasia (i.e. Spina Bifida, Cerebral Palsy), * inability to follow up (i.e. doesn't live in surrounding area), * frankly dislocated hips that require immediate treatment, * any medical condition precluding safe hip ultrasound.
Where this trial is running
Fresno, California
- Community Regional Medical Center — Fresno, California, United States (Recruiting)
Study contacts
- Principal investigator: John Wiemann, MD — UCSF - Fresno
- Study coordinator: Justin Lee, MPH
- Email: Jlee@fresno.ucsf.edu
- Phone: 559-459-4372
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.